Chemoinformaics analysis of 2,2-Dimethylchroman
| Molecular Weight | 162.232 | nRot | 0 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 16 |
| Exact Molecular Weight | 162.104 | nRing | 2 |
| Solubility: LogS | -3.119 | nHRing | 1 |
| Solubility: LogP | 2.106 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 28.5071 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.668 |
| Synth | 2.752 |
| Natural Product Likeliness | 1.443 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.087 |
| Pgp-sub | 0.773 |
| HIA | 0.008 |
| CACO-2 | -4.814 |
| MDCK | 0.0000209 |
| BBB | 0.019 |
| PPB | 0.817103 |
| VDSS | 0.961 |
| FU | 0.163959 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.929 |
| CYP2c19-inh | 0.321 |
| CYP2c19-sub | 0.102 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.813 |
| CYP2d6-inh | 0.771 |
| CYP2d6-sub | 0.779 |
| CYP3a4-inh | 0.204 |
| CYP3a4-sub | 0.323 |
| CL | 7.717 |
| T12 | 0.55 |
| hERG | 0.006 |
| Ames | 0.126 |
| ROA | 0.356 |
| SkinSen | 0.096 |
| Carcinogencity | 0.904 |
| EI | 0.109 |
| Respiratory | 0.121 |
| NR-Aromatase | 0.74 |
| Antiviral | No |
| Prediction | 0.767378 |